Bullboard - Stock Discussion Forum Cognetivity Neurosciences Ltd C.CGN

Alternate Symbol(s): CGNSF

Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial and consumer environments for potentially allowing early diagnosis of dementia. The Company’s ICA uses artificial intelligence and machine learning techniques to detect the earliest signs of... see more

Add To Watchlist

CSE:CGN - Post Discussion

Cognetivity Neurosciences Ltd > Biogen FDA approval for latest Alzheimer's drug

View:

Post by jolew32 on Jan 06, 2023 3:41pm

Biogen FDA approval for latest Alzheimer's drug

Unfortunately Roche's Alzheimer's drug didn't get approved even though Roche was looking into using CognICA to test the general population for early Alzheimer's patients who would benefit from it.

Now that Eisai & Biogen got FDA fast track approval today (Jan 6, 2023) for their latest Alzheimer's drug Lecanemab, they will now need a way to be able to test the general population as well for potential early Alzheimer's patients who can benefit from their new Alzheimer's drug that looks much more promising than their last Alzheimer's drug (it got better results in Clinical 3 trials with a lot less controversy).

On Dec 22, 2022, Eisai applied to China to get Lecanemab approved for the Chinese market which is the largest in the world.

I hope CGN is already working on getting CognICA approved for the China market so that Eisai & Biogen can use it to identify early Alzheimer's patients in China.

133